Nutra Pharma Unveils Updated Websites
January 25, 2018 08:30 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., Jan. 25, 2018 (GLOBE NEWSWIRE) -- —via OTC PR WIRE-- -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis...
Nutra Pharma Partners with EuroAmerican IP to Distribute Nyloxin® for Sale to Government Agencies
January 18, 2018 09:45 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., Jan. 18, 2018 (GLOBE NEWSWIRE) -- -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the...
Nutra Pharma Letter to Shareholders
December 29, 2017 15:36 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain...
Nutra Pharma Announces Infrastructure Improvements to Handle Increased Sales
July 24, 2014 08:00 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., July 24, 2014 (GLOBE NEWSWIRE) -- Nutra Pharma Corp. (OTCPink:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple...
Nutra Pharma Reports Final Analysis of ReceptoPharm's Multiple Sclerosis Drug in Microarray Studies
March 02, 2005 15:30 ET
|
Nutra Pharma Corp.
BOYNTON BEACH, Fla., March 2, 2005 (PRIMEZONE) -- Nutra Pharma Corp., (OTCBB:NPHC) a biotechnology holding company that owns rights to intellectual property related to the development of drugs for...